Clinical Trial Update: EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease

View source ↗

Summary

A completed registry study evaluating the XIENCE V everolimus-eluting stent in patients with multi-vessel coronary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Restenosis
• Coronary Artery Stenosis

Drugs mentioned

• XIENCE V (everolimus-eluting stent)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Disease, Coronary Artery Disease | Status: COMPLETED